BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9926966)

  • 1. Bisphosphonates for metastatic bone pain.
    Body JJ
    Support Care Cancer; 1999 Jan; 7(1):1-3. PubMed ID: 9926966
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer.
    Paterson AH; Kanis JA; Powles TJ; McCloskey E; Hanson J; Ashley S
    Can J Oncol; 1995 Dec; 5 Suppl 1():54-7. PubMed ID: 8853526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of bisphosphonates in the treatment of bone metastases--the U.S. experience.
    Harvey HA; Lipton A
    Support Care Cancer; 1996 May; 4(3):213-7. PubMed ID: 8739655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone and cancer: pathophysiology and treatment of metastases.
    Kanis JA
    Bone; 1995 Aug; 17(2 Suppl):101S-105S. PubMed ID: 8579890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
    Body JJ; Bartl R; Burckhardt P; Delmas PD; Diel IJ; Fleisch H; Kanis JA; Kyle RA; Mundy GR; Paterson AH; Rubens RD
    J Clin Oncol; 1998 Dec; 16(12):3890-9. PubMed ID: 9850035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe prolonged hypocalcaemia following pamidronate for malignant hypercalcaemia.
    Sims EC; Rogers PB; Besser GM; Plowman PN
    Clin Oncol (R Coll Radiol); 1998; 10(6):407-9. PubMed ID: 9890546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of bisphosphonates in cancer patients.
    Body JJ; Coleman RE; Piccart M
    Cancer Treat Rev; 1996 Jul; 22(4):265-87. PubMed ID: 9025784
    [No Abstract]   [Full Text] [Related]  

  • 8. Rationale for the use of bisphosphonates in breast cancer.
    Kanis JA
    Acta Oncol; 1996; 35 Suppl 5():61-7. PubMed ID: 9142969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should bisphosphonates be standard therapy for bone pain?
    Paterson AH
    Support Care Cancer; 1997 May; 5(3):200-4. PubMed ID: 9176965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic effects of pamidronate in patients with metastatic bone disease.
    Vinholes J; Guo CY; Purohit OP; Eastell R; Coleman RE
    Br J Cancer; 1996 May; 73(9):1089-95. PubMed ID: 8624269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aredia: the once-monthly infusion for the treatment of bone metastases.
    Lipton A
    Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S1-5. PubMed ID: 9801852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonates in the treatment of malignant bone disease.
    Berenson JR; Lipton A
    Annu Rev Med; 1999; 50():237-48. PubMed ID: 10073275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bisphosphonates and bone metastases].
    Lortholary A; Jadaud E; Berthaud P
    Bull Cancer; 1999 Sep; 86(9):732-8. PubMed ID: 10519966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale for the use of bisphosphonates in bone metastases.
    Kanis JA; McCloskey EV; Taube T; O'Rourke N
    Bone; 1991; 12 Suppl 1():S13-8. PubMed ID: 1954047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group.
    Hortobagyi GN; Theriault RL; Porter L; Blayney D; Lipton A; Sinoff C; Wheeler H; Simeone JF; Seaman J; Knight RD
    N Engl J Med; 1996 Dec; 335(24):1785-91. PubMed ID: 8965890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analgesic effect of bisphosphonates on bone pain in breast cancer patients: a review article.
    Strang P
    Acta Oncol; 1996; 35 Suppl 5():50-4. PubMed ID: 9142965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of metastatic bone disease in breast cancer: bisphosphonates.
    Diel IJ; Solomayer EF; Bastert G
    Clin Breast Cancer; 2000 Apr; 1(1):43-51. PubMed ID: 11899389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pamidronate in the treatment of bone metastases from breast cancer].
    Nagykálnai T; Landherr L; Zatkóné GP; Gyuricska A
    Magy Onkol; 2002; 46(3):225-33. PubMed ID: 12368918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zoledronate in a patient with pamidronate refractory hypercalcemia syndrome.
    Wenzel C; Bartsch R; Hussian D; Pluschnig U; Locker GJ; Sevelda U; Zielinski CC; Steger GG
    Support Care Cancer; 2004 Sep; 12(9):678-81. PubMed ID: 15160319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonates may be useful in treatment of bone metastases.
    Jones J
    J Natl Cancer Inst; 2001 Jul; 93(14):1052-3. PubMed ID: 11459865
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.